Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | AMGN | VRTX | REGN | GILD |
| Company | Phasebio Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0800 | 311.49 | 477.52 | 1,042.28 | 68.24 |
| High | 0.0920 | 312.54 | 477.52 | 1,047.24 | 68.33 |
| Low | 0.0665 | 306.11 | 466.01 | 1,011.67 | 66.58 |
| Last | 0.0701 | 309.38 | 470.28 | 1,024.09 | 66.59 |
| Change | -0.0249 | -1.39 | -3.50 | -20.57 | -1.81 |
| % Change | -26.21% | -0.45% | -0.74% | -1.97% | -2.65% |
| Volume | 9,647,400 | 1,000,700 | 708,600 | 378,300 | 3,995,600 |
| 20-Day Average Volume | 3,930,150 | 2,390,810 | 1,262,750 | 478,105 | 9,198,215 |
| Previous Close | 0.0950 | 310.77 | 473.78 | 1,044.66 | 68.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 307.83 | 475.62 | 1,036.33 | 66.64 |
| 20-Day Raw Stochastic | 2.27% | 45.68% | 30.39% | 37.55% | 41.13% |
| 20-Day Relative Strength | 20.88% | 54.48% | 57.80% | 53.75% | 48.68% |
| Weighted Alpha | -91.26 | +35.51 | +40.27 | +43.33 | -13.70 |
| Today's Opinion | 100% Sell | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Previous Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 72% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | -1.10% since 06/26/24 | -0.78% since 06/26/24 | -4.22% since 06/26/24 | -3.92% since 06/26/24 |
| Low | 0.0665 on 11/02/22 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.58 on 07/03/24 |
| High | 0.1440 on 10/27/22 | 319.00 on 07/01/24 | 478.96 on 07/01/24 | 1,073.05 on 06/27/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | +0.64% since 06/03/24 | +0.02% since 06/03/24 | +3.50% since 06/03/24 | +4.98% since 06/03/24 |
| Low | 0.0665 on 11/02/22 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 986.64 on 06/04/24 | 62.69 on 06/18/24 |
| High | 0.2250 on 10/14/22 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | +12.74% since 04/03/24 | +15.04% since 04/03/24 | +7.69% since 04/03/24 | -6.07% since 04/03/24 |
| Low | 0.0665 on 11/02/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.3800 on 08/09/22 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | +2.89% since 01/03/24 | +14.50% since 01/03/24 | +11.61% since 01/03/24 | -20.23% since 01/03/24 |
| Low | 0.0665 on 11/02/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.3800 on 08/09/22 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 165,962,256 | 121,357,168 | 112,840,368 | 82,961,352 |
| Shares Outstanding, K | 49,858 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 10,830,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -131,070,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 210,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -16,670,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 2.57 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 11/09/22 | 08/01/24 | 08/01/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.68 | 31.46 | 28.15 | 16.97 |